Work

565 POSTER Activity of the anti-IGF-IR antibody CP-751,871 in combination with docetaxel as first-line treatment for castration resistant prostate cancer in a randomized Phase II trial

Year: 2008

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(08)72499-6

Authors: J.S. De Bono, D.P. Petrylak, E. Calvo, F. Saad, G.R. Hudes, M.M. Cooney, M.N. Pollak, D.B. Agus, S. Gillessen, J. Scranton

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2074564758

Cites:

Cited by: 1

Related to: 10